Preferred Homecare / Lifecare Solutions

Preferred Homecare™ provides specialized home healthcare services and products focused on respiratory therapy and durable medical equipment, ensuring patients receive personalized care in the comfort of their homes. Preferred Homecare™ specializes in home healthcare services, particularly in ventilator care and respiratory therapy. Founded in 1997 in Phoenix, US, the company underwent acquisition by Lincare Holdings, Inc. in March 2019.

The founder's detailed history is not available, and there are no known subsidiaries. The company has completed 4 deals, with the latest funding round being a Buyout amounting to USD 17. 00 mn, raising a total of USD 17. 00 mn to date.

Preferred Homecare™ offers a comprehensive suite of healthcare services and products centered on home ventilator care, respiratory therapy, and durable medical equipment (DME). Their core offerings include home ventilators, nebulizers, oxygen therapy solutions, and enteral therapy products, catering to pediatric patients, individuals with chronic respiratory conditions, and those needing assistance with nutrition and wound care. Services are delivered by trained Healthcare Specialists, ensuring personalized support from hospital discharge to home integration across various urban markets in the United States. Preferred Homecare™ generates revenue through direct-to-consumer sales, partnerships with healthcare providers, and affiliations with medical professionals.

Their financial model includes subscription services for ongoing care and one-time sales of medical equipment. Core services include home ventilator therapy and PAP (Positive Airway Pressure) services, with pricing tailored to client needs, emphasizing high-quality, personalized healthcare directly in patients' homes. Moving forward, Preferred Homecare™ is assessing the introduction of new products and services aimed at improving patient care. Specific details on upcoming launches have not been disclosed.

The company intends to expand its market presence within the United States, although specific regions targeted for this growth are not detailed. The funding received in March 2019 will likely support these initiatives and facilitate operational expansions.